Siegel RL, Miller KD, Jemal A. Cancer statistics, 2020. CA Cancer J Clin. 2020;70(1):7–30.
PubMed
Google Scholar
Wu F, Wang L, Zhou C. Lung cancer in China: current and prospect. Curr Opin Oncol. 2021;33(1):40–6.
Article
CAS
PubMed
Google Scholar
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69(1):7–34.
Article
PubMed
Google Scholar
Miller KD, Nogueira L, Mariotto AB, Rowland JH, Yabroff KR, Alfano CM, Jemal A, Kramer JL, Siegel RL. Cancer treatment and survivorship statistics, 2019. CA Cancer J Clin. 2019;69(5):363–85.
Article
PubMed
Google Scholar
Noone A, Howlader N, Krapcho M. SEER Cancer Statistics Review, 1975–2015; Based on November 2017 SEER data submission, posted to the SEER website April 2018. Bethesda: National Cancer Institute; 2018. p. 2019.
Google Scholar
Detterbeck FC, Boffa DJ, Kim AW, Tanoue LT. The Eighth Edition Lung Cancer Stage Classification. Chest. 2017;151(1):193–203.
Article
PubMed
Google Scholar
Goldstraw P, Chansky K, Crowley J, Rami-Porta R, Asamura H, Eberhardt WE, Nicholson AG, Groome P, Mitchell A, Bolejack V. The IASLC lung cancer staging project: proposals for revision of the TNM stage groupings in the forthcoming (Eighth) edition of the TNM classification for lung cancer. J Thorac Oncol. 2016;11(1):39–51.
Article
PubMed
Google Scholar
Chansky K, Sculier JP, Crowley JJ, Giroux D, Van Meerbeeck J, Goldstraw P. The International Association for the Study of Lung Cancer Staging Project: prognostic factors and pathologic TNM stage in surgically managed non-small cell lung cancer. J Thorac Oncol. 2009;4(7):792–801.
Article
PubMed
Google Scholar
Kawaguchi T, Takada M, Kubo A, Matsumura A, Fukai S, Tamura A, Saito R, Maruyama Y, Kawahara M, Ignatius Ou SH. Performance status and smoking status are independent favorable prognostic factors for survival in non-small cell lung cancer: a comprehensive analysis of 26,957 patients with NSCLC. J Thorac Oncol. 2010;5(5):620–30.
Article
PubMed
Google Scholar
Pan H, Shi X, Xiao D, He J, Zhang Y, Liang W, Zhao Z, Guo Z, Zou X, Zhang J, et al. Nomogram prediction for the survival of the patients with small cell lung cancer. J Thorac Dis. 2017;9(3):507–18.
Article
PubMed
PubMed Central
Google Scholar
Wang S, Yang L, Ci B, Maclean M, Gerber DE, Xiao G, Xie Y. Development and Validation of a Nomogram Prognostic Model for SCLC Patients. J Thorac Oncol. 2018;13(9):1338–48.
Article
PubMed
PubMed Central
Google Scholar
Liang W, Zhang L, Jiang G, Wang Q, Liu L, Liu D, Wang Z, Zhu Z, Deng Q, Xiong X, et al. Development and validation of a nomogram for predicting survival in patients with resected non-small-cell lung cancer. J Clin Oncol. 2015;33(8):861–9.
Article
PubMed
Google Scholar
Zheng XQ, Huang JF, Lin JL, Chen L, Zhou TT, Chen D, Lin DD, Shen JF, Wu AM. Incidence, prognostic factors, and a nomogram of lung cancer with bone metastasis at initial diagnosis: a population-based study. Transl Lung Cancer Res. 2019;8(4):367–79.
Article
PubMed
PubMed Central
Google Scholar
Wei RL, Zhang LW, Li JG, Yang FD, Xue YK, Wei XT. Behavior-Oriented Nomogram for the Stratification of Lower-Grade Gliomas to Improve Individualized Treatment. Front Oncol. 2020;10:538133.
Article
PubMed
PubMed Central
Google Scholar
Vickers AJ, Elkin EB. Decision curve analysis: a novel method for evaluating prediction models. Med Decis Making. 2006;26(6):565–74.
Article
PubMed
PubMed Central
Google Scholar
Zuo Z, Zhang G, Song P, Yang J, Li S, Zhong Z, Tan Q, Wang L, Xue Q, Gao S, et al. Survival nomogram for stage IB non-small-cell lung cancer patients, based on the SEER database and an external validation cohort. Ann Surg Oncol. 2021;28(7):3941–50.
Article
PubMed
Google Scholar
Zhang J, Fan J, Yin R, Geng L, Zhu M, Shen W, Wang Y, Cheng Y, Li Z, Dai J, et al. A nomogram to predict overall survival of patients with early stage non-small cell lung cancer. J Thorac Dis. 2019;11(12):5407–16.
Article
PubMed
PubMed Central
Google Scholar
Zeng Y, Mayne N, Yang CJ, D’Amico TA, Ng CSH, Liu CC, Petersen RH, Rocco G, Brunelli A, Liu J, et al. A Nomogram for Predicting Cancer-Specific Survival of TNM 8th Edition Stage I Non-small-cell Lung Cancer. Ann Surg Oncol. 2019;26(7):2053–62.
Article
PubMed
Google Scholar
Li C, Liu J, Lin J, Li Z, Shang X, Wang H. Poor survival of non-small-cell lung cancer patients with main bronchus tumor: a large population-based study. Future Oncol. 2019;15(24):2819–27.
Article
CAS
PubMed
Google Scholar
Lee HW, Lee CH, Park YS. Location of stage I-III non-small cell lung cancer and survival rate: systematic review and meta-analysis. Thorac Cancer. 2018;9(12):1614–22.
Article
PubMed
PubMed Central
Google Scholar
Pasello G, Zago G, Lunardi F, Urso L, Kern I, Vlacic G, Grosso F, Mencoboni M, Ceresoli GL, Schiavon M, et al. Malignant pleural mesothelioma immune microenvironment and checkpoint expression: correlation with clinical-pathological features and intratumor heterogeneity over time. Ann Oncol. 2018;29(5):1258–65.
Article
CAS
PubMed
Google Scholar
Agarwal M, Brahmanday G, Chmielewski GW, Welsh RJ, Ravikrishnan KP. Age, tumor size, type of surgery, and gender predict survival in early stage (stage I and II) non-small cell lung cancer after surgical resection. Lung Cancer. 2010;68(3):398–402.
Article
PubMed
Google Scholar
Rice TW, Gress DM, Patil DT, Hofstetter WL, Kelsen DP, Blackstone EH. Cancer of the esophagus and esophagogastric junction-Major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(4):304–17.
Article
PubMed
Google Scholar
Rami-Porta R, Asamura H, Travis WD, Rusch VW. Lung cancer - major changes in the American Joint Committee on Cancer eighth edition cancer staging manual. CA Cancer J Clin. 2017;67(2):138–55.
Article
PubMed
Google Scholar
Altorki N, Pass H, Miller D, Kernstine K. A phase III randomized trial of lobectomy versus sublobar resection for small (≤ 2 cm) peripheral non-small cell lung cancer. 2018.
Google Scholar
Nakamura K, Saji H, Nakajima R, Okada M, Asamura H, Shibata T, Nakamura S, Tada H, Tsuboi M. A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L). Jpn J Clin Oncol. 2010;40(3):271–4.
Article
PubMed
Google Scholar
Takamori S, Oizumi H, Suzuki J, Suzuki K, Kabasawa T. Video-Assisted Thoracoscopic Segmentectomy for Deep and Peripheral Small Lung Cancer. Thorac Cardiovasc Surg. 2022;70(3):233–38.
Darras M, Ojanguren A, Forster C, Zellweger M, Perentes JY, Krueger T, Gonzalez M. Short-term local control after VATS segmentectomy and lobectomy for solid NSCLC of less than 2 cm. Thorac Cancer. 2021;12(4):453–61.
Article
CAS
PubMed
Google Scholar
Mimae T, Okada M. Are segmentectomy and lobectomy comparable in terms of curative intent for early stage non-small cell lung cancer? Gen Thorac Cardiovasc Surg. 2020;68(7):703–6.
Article
PubMed
Google Scholar
Handa Y, Tsutani Y, Mimae T, Miyata Y, Okada M. Complex segmentectomy in the treatment of stage IA non-small-cell lung cancer. Eur J Cardiothorac Surg. 2020;57(1):114–21.
Article
PubMed
Google Scholar
Lutz JA, Seguin-Givelet A, Grigoroiu M, Brian E, Girard P, Gossot D. Oncological results of full thoracoscopic major pulmonary resections for clinical Stage I non-small-cell lung cancer. Eur J Cardiothorac Surg. 2019;55(2):263–70.
Article
PubMed
Google Scholar
Hua J, Zhang B, Xu J, Liu J, Ni Q, He J, Zheng L, Yu X, Shi S. Determining the optimal number of examined lymph nodes for accurate staging of pancreatic cancer: An analysis using the nodal staging score model. Eur J Surg Oncol. 2019;45(6):1069–76.
Article
PubMed
Google Scholar
Wang Y, Zhang J, Guo S, Dong Z, Meng X, Zheng G, Yang D, Zheng Z, Zhao Y. Implication of lymph node staging in migration and different treatment strategies for stage T2N0M0 and T1N1M0 resected gastric cancer: a SEER population analysis. Clin Transl Oncol. 2019;21(11):1499–509.
Article
CAS
PubMed
Google Scholar
Osarogiagbon RU, Ogbata O, Yu X. Number of lymph nodes associated with maximal reduction of long-term mortality risk in pathologic node-negative non-small cell lung cancer. Ann Thorac Surg. 2014;97(2):385–93.
Article
PubMed
Google Scholar
Darling GE, Allen MS, Decker PA, Ballman K, Malthaner RA, Inculet RI, Jones DR, McKenna RJ, Landreneau RJ, Rusch VW. Randomized trial of mediastinal lymph node sampling versus complete lymphadenectomy during pulmonary resection in the patient with N0 or N1 (less than hilar) non–small cell carcinoma: Results of the American College of Surgery Oncology Group Z0030 Trial. J Thorac Cardiovasc Surg. 2011;141(3):662–70.
Article
PubMed
PubMed Central
Google Scholar
Wo Y, Yang H, Zhang Y, Wo J. Development and External Validation of a Nomogram for Predicting Survival in Patients With Stage IA Non-small Cell Lung Cancer ≤2 cm Undergoing Sublobectomy. Front Oncol. 2019;9:1385.
Article
PubMed
PubMed Central
Google Scholar
Kent MS, Mandrekar SJ, Landreneau R, Nichols F, Foster NR, DiPetrillo TA, Meyers B, Heron DE, Jones DR, Tan AD, et al. A nomogram to predict recurrence and survival of high-risk patients Undergoing Sublobar Resection For Lung Cancer: an analysis of a multicenter prospective study (ACOSOG Z4032). Ann Thorac Surg. 2016;102(1):239–46.
Article
PubMed
PubMed Central
Google Scholar
Matsumura Y, Hishida T, Shimada Y, Ishii G, Aokage K, Yoshida J, Nagai K. Impact of extratumoral lymphatic permeation on postoperative survival of non-small-cell lung cancer patients. J Thorac Oncol. 2014;9(3):337–44.
Article
CAS
PubMed
PubMed Central
Google Scholar